USA flag logo/image

An Official Website of the United States Government

MINIATURIZED SENSORS FOR IN-VIVO GLUCOSE MEASUREMENT

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
7993
Program Year/Program:
1991 / SBIR
Agency Tracking Number:
7993
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Markwell Medical Institute,
1433 Valley View Drive Racine, WI 53405
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1991
Title: MINIATURIZED SENSORS FOR IN-VIVO GLUCOSE MEASUREMENT
Agency: HHS
Contract: N/A
Award Amount: $488,901.00
 

Abstract:

THIS APPLICATION PROPOSES TO DETERMINE THE FEASIBILITY OF DEVELOPING AND MASS PRODUCING A CONTINUOUS ELECTROCHEMICAL SENSOR SUITABLE FOR IN VIVO GLUCOSE MONITORING AND IMPLANTATION. THE SENSOR WILL BE COMPRISED OF A HYDROGEN PEROXIDE ELECTRODE IN CONCERT WITH AN IMMOBILIZED GLUCOSE OXIDASE MEMBRANE. RESEARCH SUPPORT IS REQUESTED TO FURTHER DEVELOP AND OPTIMIZE BOTH THE ELECTRODE AND MEMBRANCE COMPONENTS. HISTORICALLY, CONTINUOUS GLUCOSE ENZYME ELECTRODES SHOW LINEARITY, DRIFT, AND FLOW SENSITIVITY PROBLEMS, PARTICULARLY IN THE PHYSIOLOGICAL ENVIRONMENT. OUR RESEARCH HAS SHOWN THAT THIS IS DUE TO OXYGEN DEPLETION WITHIN THE MEMBRANE, WITH DIGITAL SIMULATIONS PROVIDING PREDICTION OF THE THE REQUIRED GLUCOSE/OXYGEN PERMEABILITY PROPERTIES WHICH MINIMIZE THIS PROBLEM. THIS KNOWLEDGE MADEPOSSIBLE DIRECT 30/30, THE FIRST REUSEABLE ELECTROCHEMICAL SENSOR FOR HOME GLUCOSE MONITORING THIS APPLICATION PROPOSES MODIFICATION OF THE DIRECT 30/30 TECHNOLOGY TO ALLOW IN VIVO GLUCOSE MONITORING. SYSTEMATIC MEMBRANE COMPOSITION VARIATIONS WILL BE PERFORMED TO TUNE-IN THIS APPLICATION'S REQUIRED PERMEABILITY WINDOW. THIS ADDITIONAL MEMBRANE RESEARCH, WITH APPROPRIATE ELECTRODE GEOMETRY AND MINIATURIZATION, SHOULD PRODUCE AN IMPLANTABLE SUBCUTANEOUS GLUCOSE ELECTRODE SUITABLE FOR LONG-TERM MONITORING. PHASE I WILL BE USED TO PERFORM THE MATERIAL SCREEN AND TO BUILD AND EVALUATE THE PROTOTYPE ELECTRODES. PHASE II AND III WILL BE DIRECTED TOWARDS SENSOR CLINICAL VALIDATION AND MASS PRODUCTION.

Principal Investigator:


0

Business Contact:

Small Business Information at Submission:

Markwell Medical Institute Inc
1433 Valley View Dr Racine, WI 53405

EIN/Tax ID:
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No